CARGO Therapeutics will join the Nasdaq on Friday morning in what some industry insiders think could be the final, maybe penultimate, initial public offering for a biotech this year.
The CAR-T cell therapy maker will raise about $281 million by selling 18.75 million shares at $15 apiece {CRGX}, the low…
Click here to view original post
